Artivion has gone through a sharp reset in market expectations, with the share price down heavily over the past year yet still well ahead of where it was three years ago. That mix of long term gains and recent weakness puts the focus squarely on a single issue: whether the current price can be explained by the cash the business is expected to generate.

• Over the past 3 years the stock has gained 66.9%, which puts meaningful past returns on the line if the underlying cash flows do not support the present valuation.

• The business depends on converting its medical-device operations into reliable cash generation, which can shape how investors think about funding needs and the timing of any future surplus cash.

• Prefer to judge Artivion on sales? See why Artivion's 2.3x P/S tells a different valuation story .

For investors, the debate is whether Artivion's recent share price of US$22.28 is adequately backed by the cash flows implied by its intrinsic value estimate from the Discounted Cash Flow (DCF) approach.

If you are weighing whether Artivion's cash flows justify the current share price, it can help to compare that question against a wider set of companies filtered through 35 high quality undervalued stocks

Does Artivion Look Undervalued on Cash Flow?

The Discounted Cash Flow (DCF) model here looks at the cash Artivion is expected to generate for shareholders and then discounts it back to today. On the latest twelve month numbers, the business produced free cash flow of about $4.6 million, so the framework assumes a move from relatively modest recent cash generation to meaningfully larger figures over time.

Projections in the DCF imply recovering and then growing free cash flow, with analyst inputs pointing to materially higher annual cash available to equity holders by the early 2030s. When those future streams are discounted, the model places Artivion's estimated intrinsic value modestly above the current share price of US$22.28, which suggests the market is not fully reflecting those projected cash flows. Find out what Artivion could be worth using our Discounted Cash Flow (DCF) estimate .

The Artivion Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Artivion pick up where the DCF puzzle leaves off and spell out which paths for future growth, profitability and earnings would need to play out for the stock to be valued materially higher or lower than today. Each Narrative sits on the Community page and treats fair value as a thesis that can be tracked over time, so you can see how the story holds up as new information arrives.